Post Call Commentary and Updated Model
Medicine Man Technologies, Inc. is now operating under its new trade name, Schwazze. Schwazze is executing its strategy to become a leading vertically integrated cannabis holding company with a portfolio consisting of top-tier licensed brands spanning cultivation, extraction, infused-product manufacturing, dispensary operations, consulting, and a nutrient line. Schwazze leadership includes Colorado cannabis leaders with proven expertise in product and business development as well as top-tier executives from Fortune 500 companies. As a leading platform for vertical integration, Schwazze is strengthening the operational efficiency of the cannabis industry in Colorado and beyond, promoting sustainable growth and increased access to capital, while delivering best-quality service and products to the end consumer. The corporate entity continues to be named Medicine Man Technologies, Inc.
Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.
Joshua Zoepfel, Research Associate, Noble Capital Markets, Inc.
Refer to the full report for the price target, fundamental analysis, and rating.
Post Management Call. We had an opportunity to speak with Schwazze CEO Justin Dye and CFO Nancy Huber following the release of fourth quarter earnings. Our discussion revolved around the Colorado and New Mexico operations, what’s next for those operations, and where the Company can go from here, including potential additional expansion.
Implementing the Playbook. All but one of the announced acquisitions has now been closed. We view 2022 as a year of integrating the acquisitions and implementing the Schwazze operating playbook to drive revenue and margins. While the cannabis market will see ebbs and flows, we expect Schwazze to…
This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).
*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.